In vivo models, such as injecting tumor cells into mice and treating with inhibitors, have shown how these compounds can slow metastasis in real biological systems, like in pancreatic cancer models where FAK inhibitors reduced tumor spread to the liver20. This evidence concerns the gene PTK2 and neoplasm.